Literature DB >> 24953287

Effectiveness of involving pharmacists in the process of ambulatory health care to improve drug treatment adherence and disease control.

Dolores Mino-León1, Hortensia Reyes-Morales, Sergio Flores-Hernández.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: To evaluate the effectiveness of incorporating the pharmacist into the ambulatory health care team to increase the proportion of patients with type 2 diabetes mellitus (T2DM) and/or hypertension who adhere to their drug regimen and to improve disease control.
METHODS: A non-randomized clinical trial was carried out in patients with T2DM and/or hypertension from two primary care clinics. Patients from one of the clinics comprised the intervention group (IG) who received 'counselling' from the pharmacist. The control group (CG) was comprised of patients who attended another clinic and received the usual care. Adherence was measured by counting pills; hypertension control was evaluated by blood pressure and diabetes control by blood glucose. Statistical analysis was carried out by intention to treat using generalized linear models.
RESULTS: There were 440 patients included. There was no difference in the proportion of IG and CG patients who adhered to treatment according to baseline measurements. An increase in the proportion of adherence at baseline and final determination was observed in both groups (IG 71-80%, P=0.006 and CG 72-87%, P=0.000). Generalized linear models showed a 55% or higher probability of IG patients achieving control of hypertension in comparison with the CG. Patients from the IG with T2DM have 13% more possibility of achieving glycaemic control than those of the CG.
CONCLUSION: Counselling offered by the pharmacist proved to be effective for improving drug adherence of diabetic and hypertensive patients in ambulatory health care.
© 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adherence; diabetes mellitus; disease control; hypertension; pharmacist; primary care

Mesh:

Substances:

Year:  2014        PMID: 24953287     DOI: 10.1111/jep.12207

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  7 in total

Review 1.  Quasi experimental designs in pharmacist intervention research.

Authors:  Ines Krass
Journal:  Int J Clin Pharm       Date:  2016-01-29

2.  Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients.

Authors:  Julia R Smith; Lisa Hillman; Paul E Drawz
Journal:  Clin Exp Hypertens       Date:  2017-12-06       Impact factor: 1.749

3.  Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians.

Authors:  Stéphanie Sidorkiewicz; Viet-Thi Tran; Cécile Cousyn; Elodie Perrodeau; Philippe Ravaud
Journal:  Ann Fam Med       Date:  2016-09       Impact factor: 5.166

4.  Improving Chronic Disease Outcomes Through Medication Therapy Management in Federally Qualified Health Centers.

Authors:  Jennifer L Rodis; Alexa Sevin; Magdi H Awad; Brianne Porter; Kyle Glasgow; Carrie Hornbeck Fox; Barbara Pryor
Journal:  J Prim Care Community Health       Date:  2017-04-05

5.  Impact of clinical pharmacist-led diabetes management clinic on health outcomes at an academic hospital in Riyadh, Saudi Arabia: A prospective cohort study.

Authors:  Bashayr Alsuwayni; Abdulaziz Alhossan
Journal:  Saudi Pharm J       Date:  2020-11-11       Impact factor: 4.330

6.  The impact of pharmacists providing direct patient care as members of interprofessional teams on diabetes management.

Authors:  Osamah M Alfayez; Majed S Al Yami; Maryam T Fazel
Journal:  Saudi Pharm J       Date:  2017-03-22       Impact factor: 4.330

7.  Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study.

Authors:  Cesar I Fernandez-Lazaro; Juan M García-González; David P Adams; Diego Fernandez-Lazaro; Juan Mielgo-Ayuso; Alberto Caballero-Garcia; Francisca Moreno Racionero; Alfredo Córdova; Jose A Miron-Canelo
Journal:  BMC Fam Pract       Date:  2019-09-14       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.